Literature DB >> 16330460

Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation.

Arianne Pérez-García, Rafael De la Cámara, Antonio Torres, Marcos González, Antonio Jiménez, David Gallardo.   

Abstract

We analyzed the clinical outcome of 146 adult patients receiving an HLA-identical sibling donor stem cell transplant depending on HA-8 matching status. The presence of an HA-8 mismatch was associated with an increased risk of severe acute graft-versus-host disease and with a worse overall survival.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16330460

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  8 in total

1.  Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT.

Authors:  A Bosch-Vizcaya; R Rodriguez-Romanos; J B Nieto; R de la Cámara; S Brunet; C Vallejo; G Osca-Gelis; C Martínez-Laperche; I Buño; Á Urbano-Ispizúa; M González; A Jiménez-Velasco; D Gallardo
Journal:  Bone Marrow Transplant       Date:  2014-10-20       Impact factor: 5.483

Review 2.  Immunotherapeutic approaches to treat multiple myeloma.

Authors:  Mieke W H Roeven; Willemijn Hobo; Nicolaas Schaap; Harry Dolstra
Journal:  Hum Vaccin Immunother       Date:  2013-12-11       Impact factor: 3.452

3.  Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation.

Authors:  Willemijn Hobo; Kelly Broen; Walter J F M van der Velden; Annelies Greupink-Draaisma; Niken Adisty; Yannick Wouters; Michel Kester; Hanny Fredrix; Joop H Jansen; Bert van der Reijden; J H Frederik Falkenburg; Theo de Witte; Frank Preijers; Ton Schattenberg; Ton Feuth; Nicole M Blijlevens; Nicolaas Schaap; Harry Dolstra
Journal:  Biol Blood Marrow Transplant       Date:  2012-09-27       Impact factor: 5.742

Review 4.  Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.

Authors:  Xin Feng; Kwok Min Hui; Hashem M Younes; Anthony G Brickner
Journal:  Trends Immunol       Date:  2008-10-25       Impact factor: 16.687

5.  Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.

Authors:  Stephen Spellman; Melissa B Warden; Michael Haagenson; Bradley C Pietz; Els Goulmy; Edus H Warren; Tao Wang; Thomas M Ellis
Journal:  Biol Blood Marrow Transplant       Date:  2009-07       Impact factor: 5.742

Review 6.  Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives.

Authors:  R Oostvogels; H M Lokhorst; T Mutis
Journal:  Bone Marrow Transplant       Date:  2015-10-26       Impact factor: 5.483

7.  Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors.

Authors:  Monika Dzierzak-Mietla; M Markiewicz; Urszula Siekiera; Sylwia Mizia; Anna Koclega; Patrycja Zielinska; Malgorzata Sobczyk-Kruszelnicka; Slawomira Kyrcz-Krzemien
Journal:  Bone Marrow Res       Date:  2012-11-08

8.  Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor.

Authors:  Federica Cattina; Simona Bernardi; Vilma Mantovani; Eleonora Toffoletti; Alessandra Santoro; Domenico Pastore; Bruno Martino; Giuseppe Console; Giovanni Martinelli; Michele Malagola
Journal:  Hematol Rep       Date:  2017-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.